Panakes derives from Panacea (Greek Πανάκεια, Panakeia), who was the goddess of Universal remedy, said to have a potion
with which she healed the sick.
Panakes Partners is a Venture Capital investor that finances medical companies, early stage startup and SMEs, with extremely promising products and great ambition, in Europe and Israel.
Thanks to our strong entrepreneurial and financial experiences we provide more than capital, and we aim to work together with entrepreneurs to develop successful businesses as an active and well-connected investor. We also have strong relationship with selected industrial partners to help companies to accelerate their development.
We seek and help to grow Medtech companies with the potential to have a positive impact on society. We believe such opportunities create the most value for all parties.
From our office in Milan, Panakes is willing to back the smartest entrepreneurs with the best technologies and ideas.
Antonio Biscini VP Biz Dev MENARINI
Antonio heads Business Development & Licensing at Menarini, the largest Italian pharmaceutical group with over 4.2b$ sales in 2013
Gabriele Cogliati Founder and CEO ELEMASTER
Gabriele has built and leads the Italian leader in designing and developing electronic technologies for command, control and regulation devices of medical use
Laura Iris Ferro Founder and former CEO GENTIUM
Laura is a Successful entrepreneur who has built and sold Gentium, leader in the development and of active ingredients derived from natural sources as potential therapeutic agents, sold to Jazz Pharmaceuticals for 1b$ in 2013
Emanuele Gatti Former CEO EMEA and Board Member FRESENIUS MEDICAL CARE
Emanuele has a life-long experience in the dialysis and kidney failures business, serving for almost 20 years as top Executive and Board Member in Fresenius, a dialysis global leader
Giuseppe Prisco Former Managing Principal INTUITIVE SURGICAL
Giuseppe led the technical R&D efforts at Intuitive Surgical in its very early days, a company who is now the undiscussed leader in medical robotic, with a mkt cap of 18b$
Lorenzo Tallarigo Former Board Member of INTERCEPT and executive of ELI LILLY
Lorenzo has played a key role in the Intercept story since its early days as a member of the board and as lead investor. Intercept is now a public company with a market cap over 4b$. Lorenzo has also an extensive carrier as an Executive in leading Life Sciences companies
Maurizio Colombo Founder of Sapio Group and President of Sapio Life
Maurizio is an entrepreneur at the forefront of the innovation in the sectors of gases and of the services related to Hospital and remote Patient Assistance.
Lucio Rovati Founder of Rottapharm and CEO / CSO of Rottapharm Biotech
Lucio is a successful entrepreneur and experienced CSO, who has built Rottapharm, leader in research, development, manufacturing, global marketing and distribution of branded clinically proven consumer healthcare products, reimbursed prescription products and natural extracts.and of active ingredients derived from natural sources as potential therapeutic agents, sold to Meda for 3.1b$ in 2014
Menarini is an Italian company, leader in the pharmaceuticals and diagnostics sectors.
Elemaster Group is today a leading international player in the Original Design Manufacturing and Electronic Manufacturing Services: in the design and production of electronic equipment with high technological content.
The IIT is intended to promote Italy's technological development and advanced education, consistent with national policies for scientific and technological development, thus strengthening the national production system.
Scuola Superiore Sant'Anna
Incubator for spin-offs from research from Scuola Superiore Sant'Anna in technologies for the elderly and biomedical.
Toscana Life Sciences
Park and incubator dedicated to Life Sciences technology.
Humanitas Research Hospital is the flagship hospital of Humanitas Group. It is a highly specialized hospital, research and teaching center, accredited by the National Health-Care System, with the mission of providing people with outstanding and highly specialized diagnostic and therapeutic services.
European Investment Fund & European Commission
Panakes is supported by the INNOVFIN SME Venture Capital with the financial backing of the European Union under Horizon 2020 Financial Instruments established under Regulation (No) 1291/2013 of the European Parliament and the Council establishing Horizon 2020 – the Framework Programme for Research and Innovation (2014-2020)][through financial backing of the European Union under the Equity Facility for Growth established under Regulation (EU) No 1287/2013 of the European Parliament and the Council establishing a Programme for the Competitiveness of Enterprises and small and medium enterprises (COSME) (2014-2020)
Fondo Italiano D'Investimento
Fondo Italiano d’Investimento SGR is a management company promoted by the Italian Ministry of Finance with the co-operation of Associazione Bancaria Italiana (Italian Banking Association), Cassa Depositi e Prestiti, Confindustria (Industrial Association), Intesa Sanpaolo, Banca Monte dei Paschi di Siena and Unicredit. Today, it manages three closed-end funds for a total amount of EUR 1.7 billion:”Fondo Italiano di Investimento”, ”FoF Private Debt” and ”FoF Venture Capital”.
Milan, 15 February 2015
Milan, 8 march 2016
|Tweet di @panakes|